Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000038756 | SCV000051556 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038756 | SCV000062434 | likely benign | not specified | 2015-05-18 | criteria provided, single submitter | clinical testing | p.Val118Met in exon 4 of LDB3: This variant is not expected to have clinical sig nificance because it has been identified in 0.7% (455/63354) of European chromos omes including 1 homozygous individual by the Exome Aggregation Consortium (http ://exac.broadinstitute.org/; dbSNP rs35507268). |
Gene |
RCV000038756 | SCV000170108 | benign | not specified | 2013-02-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000232676 | SCV000289623 | benign | Myofibrillar myopathy 4 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003891486 | SCV000311693 | benign | LDB3-related disorder | 2019-10-25 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Eurofins Ntd Llc |
RCV000038756 | SCV000333572 | likely benign | not specified | 2015-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621725 | SCV000736178 | likely benign | Cardiovascular phenotype | 2018-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770140 | SCV000901566 | benign | Cardiomyopathy | 2016-08-17 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000770140 | SCV000995321 | benign | Cardiomyopathy | 2019-02-26 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001528350 | SCV001159526 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528350 | SCV002563021 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | LDB3: BP4, BS2 |
Fulgent Genetics, |
RCV002496617 | SCV002796783 | benign | Dilated cardiomyopathy 1C; Myofibrillar myopathy 4 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000038756 | SCV000212126 | likely benign | not specified | 2015-03-02 | no assertion criteria provided | research | |
Diagnostic Laboratory, |
RCV001528350 | SCV001739966 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001528350 | SCV001797960 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000038756 | SCV001922589 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528350 | SCV001929216 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000038756 | SCV001951905 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000038756 | SCV001964107 | benign | not specified | no assertion criteria provided | clinical testing |